Nifedipine Tablet, Extended Release
Product Images NDC 60760-862

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 60760-862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

862-90 (Nifedipine 60760 862 90)

This is a label for Nifedipine Extended-Release Tablets, USP 90mg. The tablets are manufactured by Phamaceudicals, LLC in Orlando, FL and made in China. They are packaged by S IIIPP in Oro Valley, AZ. The label includes NDC number, Lot Number, Expiration Date, and Quantity. It is advised to use the medication as directed and store at controlled room temperature.*

FDA Label Image

01 (Image 01)

FDA Label Image

02 (Image 02)

FDA Label Image

03 (Image 03)

This is a comparison between the adverse effects reported for Nifedipine capsules and Placebo. The data shows the percentage of patients experiencing different adverse effects such as dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat in a study with 226 participants for Nifedipine and 235 for Placebo.*

FDA Label Image

04 (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.